Fol. Biol. 2004, 50, 200-202
https://doi.org/10.14712/fb2004050060200
The Role of NK1.1+ Cells in the Protection against MHC Class I+ HPV16-Associated Tumours
References
1. , A., Baron, J. L., Lanier, L. L. (2001) Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98, 11521-11526.
<https://doi.org/10.1073/pnas.201238598>
2. , K., Ljunggren, H. G., Piontek, G., Kiessling, R. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678.
<https://doi.org/10.1038/319675a0>
3. , G. C., Dumont, F. J., Tutt, M., Hackett, J. Jr., Kumar, V. (1986) The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J. Immunol. 137, 3742-3747.
<https://doi.org/10.4049/jimmunol.137.12.3742>
4. , K.-Y., Guarnieri, F. G., Staveley-OíCarroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., Wu, T.-C. (1996) Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56, 21-26.
5. , H. G., Karre, K. (1990) In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
<https://doi.org/10.1016/0167-5699(90)90097-S>
6. , A., Sasaki, H., Aoyagi, K., Yoshida, M., Kato, K. et al. (2004) The mouse natural killer T cell-associated antigen recognized by U5A2-13 monoclonal antibody is intercellular adhesion molecule-1. Immunol. Lett. 92, 227-235.
<https://doi.org/10.1016/j.imlet.2004.01.005>
7. , M., Šíma, P., Ludvíková, V., Marinov, I., Pokorná, D., Vonka, V. (2003) Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules. Vaccine 21, 1125-1136.
<https://doi.org/10.1016/S0264-410X(02)00519-4>
8. , M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H., Godfrey, D. I. (2002) NKT cells ñ conductors of tumor immunity? Curr. Opin. Immunol. 14, 165-171.
<https://doi.org/10.1016/S0952-7915(02)00316-3>
9. , T. J., Smyth, M. J., Fernando, G. J. P., Frazer, I. H., Leggatt, G. R. (2003) Inhibition of early tumour growth require Jα18-positive (natural killer T) cells. Cancer Res. 63, 3058-3060.
